Published on in Vol 7 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/42418, first published
.
Journals
- Cooper L, Rosen J, Zhang L, Pelaez D, Olatunde P, Owczarzak J, Park J, Glick J. Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study. Harm Reduction Journal 2023;20(1) View
- Zhang L, Rosen J, Cooper L, Olatunde P, Pelaez D, Sherman S, Park J, Glick J. Interrogating perceived relevance and feasibility of HIV pre-exposure prophylaxis: A novel model of PrEP acceptability among cisgender women who inject drugs. SSM - Qualitative Research in Health 2023;4:100337 View
- Strathdee S, Abramovitz D, Harvey-Vera A, Stamos-Buesig T, Vera C, Artamonova I, Logan J, Patterson T, Servin A, Bazzi A. A Brief Peer-Led Intervention to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs in San Diego County: Results From a Pilot Randomized Controlled Trial. Open Forum Infectious Diseases 2023;10(8) View
- Andrzejewski J, Pines H, Morris S, Burke L, Bolan R, Sevelius J, Moore D, Blumenthal J. Determinants of HIV Pre-Exposure Prophylaxis (PrEP) Retention among Transgender Women: A Sequential, Explanatory Mixed Methods Study. International Journal of Environmental Research and Public Health 2024;21(2):133 View
- Pimenta M, Torres T, Hoagland B, Cohen M, Mann C, Jalil C, Carvalheira E, Freitas L, Fernandes N, Castanheira D, Benedetti M, Moreira J, Simpson K, Trefiglio R, O’Malley G, Veloso V, Grinsztejn B. Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study. JMIR Public Health and Surveillance 2024;10:e60961 View